Was inquiring about both. MKSAP tends to suggest you never check EGFR in squamous... I remember checking it for all non-small cell (including squamous) in clinic. Thanks.
MKSAP is right, for the boards.
I've had this discussion with roughly 90% of the new, or progressing patients, that I've seen in the last month or six.
Me: So, your disease is not responding to therapy line X anymore.
Them: Well, what do we do now?
Me: If you were a test question, this would be easy. The answer is 'B'...moar chemo!1!1!1! But you're a real person, with X, Y and Z comorbidities. So all the chemo options I have will guarantee you a miserable death in the ICU sometime in the next 2 or 3 weeks. And I'm not down with that. But if you are, I can refer you to the private group in town, they'd love to treat you.
On a somewhat related note, I've been in my current position for 8 years now. Only in the last 6 months have we gotten path to stop checking EGFR/ROS/ALK on every single thing that came out of the lung.
- 1.2cm TTF1+ adeno with 27 neg LNs in a lobectomy specimen? EGFR/ROS/ALK tested.
- 5cm low-grade NET/typical carcinoid in a lobectomy? EGFR/ROS/ALK tested...and negative.
- Core needle bx of a lung mass in a 38yo woman w/ a h/o triple neg breast cancer that shows invasive lobular carcinoma? EGFR/ROS/ALK tested and negative. But try getting them to send ER/PR and HER2 FISH.
- Mediastinoscopy for diffuse thoracic LAD. CD20+, CD19+ monoclonal lymphoid population c/w DLBCL. EGFR/ROS/ALK tested and negative.